APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonsteroidal MRAs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nonsteroidal MRAs Market Analysis and Forecast 2026-2032

29 December 2025190 pages

Choose your research edition.

Industry ResearchNonsteroidal MRAs Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonsteroidal MRAs Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Nonsteroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonsteroidal MRAs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonsteroidal MRAs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nonsteroidal MRAs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nonsteroidal MRAs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nonsteroidal MRAs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nonsteroidal MRAs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nonsteroidal MRAs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nonsteroidal MRAs include Daiichi Sankyo, Bayer and Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nonsteroidal MRAs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nonsteroidal MRAs, also provides the sales of main regions and countries. Of the upcoming market potential for Nonsteroidal MRAs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nonsteroidal MRAs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nonsteroidal MRAs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nonsteroidal MRAs sales, projected growth trends, production technology, application and end-user industry.

Nonsteroidal MRAs Segment by Company

Daiichi Sankyo

Bayer

Sun Pharma

Nonsteroidal MRAs Segment by Type

Finerenone

Esaxerenone

Others

Nonsteroidal MRAs Segment by Application

Heart Failure

Diabetic Nephropathy

Hypertension

Others

Nonsteroidal MRAs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonsteroidal MRAs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonsteroidal MRAs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonsteroidal MRAs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nonsteroidal MRAs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nonsteroidal MRAs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nonsteroidal MRAs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nonsteroidal MRAs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Finerenone Major Manufacturers Table 3. Esaxerenone Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Nonsteroidal MRAs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Heart Failure Major Manufacturers Table 7. Diabetic Nephropathy Major Manufacturers Table 8. Hypertension Major Manufacturers Table 9. Others Major Manufacturers Table 10. Nonsteroidal MRAs Industry Trends Table 11. Nonsteroidal MRAs Industry Drivers Table 12. Nonsteroidal MRAs Industry Opportunities and Challenges Table 13. Nonsteroidal MRAs Industry Restraints Table 14. Global Nonsteroidal MRAs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Nonsteroidal MRAs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Nonsteroidal MRAs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Nonsteroidal MRAs Revenue Market Share by Region (2021-2026) Table 18. Global Nonsteroidal MRAs Revenue Market Share by Region (2027-2032) Table 19. Global Nonsteroidal MRAs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nonsteroidal MRAs Sales by Region (2021-2026) & (K Units) Table 21. Global Nonsteroidal MRAs Sales by Region (2027-2032) & (K Units) Table 22. Global Nonsteroidal MRAs Sales Market Share by Region (2021-2026) Table 23. Global Nonsteroidal MRAs Sales Market Share by Region (2027-2032) Table 24. Global Nonsteroidal MRAs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Nonsteroidal MRAs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Nonsteroidal MRAs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nonsteroidal MRAs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Nonsteroidal MRAs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Nonsteroidal MRAs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Nonsteroidal MRAs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Nonsteroidal MRAs Manufacturers, Product Type & Application Table 32. Global Nonsteroidal MRAs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Nonsteroidal MRAs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Nonsteroidal MRAs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Nonsteroidal MRAs Revenue Market Share by Type (2021-2026) Table 39. Global Nonsteroidal MRAs Revenue Market Share by Type (2027-2032) Table 40. Global Nonsteroidal MRAs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 42. Global Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 43. Global Nonsteroidal MRAs Sales Market Share by Type (2021-2026) Table 44. Global Nonsteroidal MRAs Sales Market Share by Type (2027-2032) Table 45. Global Nonsteroidal MRAs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Nonsteroidal MRAs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Nonsteroidal MRAs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Nonsteroidal MRAs Revenue Market Share by Application (2021-2026) Table 51. Global Nonsteroidal MRAs Revenue Market Share by Application (2027-2032) Table 52. Global Nonsteroidal MRAs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 54. Global Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 55. Global Nonsteroidal MRAs Sales Market Share by Application (2021-2026) Table 56. Global Nonsteroidal MRAs Sales Market Share by Application (2027-2032) Table 57. Global Nonsteroidal MRAs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Nonsteroidal MRAs Price by Application (2027-2032) & (US$/Unit) Table 59. Daiichi Sankyo Company Information Table 60. Daiichi Sankyo Business Overview Table 61. Daiichi Sankyo Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Daiichi Sankyo Nonsteroidal MRAs Product Portfolio Table 63. Daiichi Sankyo Recent Development Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bayer Nonsteroidal MRAs Product Portfolio Table 68. Bayer Recent Development Table 69. Sun Pharma Company Information Table 70. Sun Pharma Business Overview Table 71. Sun Pharma Nonsteroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sun Pharma Nonsteroidal MRAs Product Portfolio Table 73. Sun Pharma Recent Development Table 74. North America Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 77. North America Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 78. North America Nonsteroidal MRAs Sales Price by Type (2021-2026) & (US$/Unit) Table 79. North America Nonsteroidal MRAs Sales Price by Type (2027-2032) & (US$/Unit) Table 80. North America Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 83. North America Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 84. North America Nonsteroidal MRAs Sales Price by Application (2021-2026) & (US$/Unit) Table 85. North America Nonsteroidal MRAs Sales Price by Application (2027-2032) & (US$/Unit) Table 86. North America Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Nonsteroidal MRAs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Nonsteroidal MRAs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 90. North America Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 91. North America Nonsteroidal MRAs Sales by Country (2027-2032) & (K Units) Table 92. North America Nonsteroidal MRAs Sales Price by Country (2021-2026) & (US$/Unit) Table 93. North America Nonsteroidal MRAs Sales Price by Country (2027-2032) & (US$/Unit) Table 94. United States Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 95. Canada Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 96. Mexico Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 97. Europe Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 100. Europe Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 101. Europe Nonsteroidal MRAs Sales Price by Type (2021-2026) & (US$/Unit) Table 102. Europe Nonsteroidal MRAs Sales Price by Type (2027-2032) & (US$/Unit) Table 103. Europe Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 106. Europe Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 107. Europe Nonsteroidal MRAs Sales Price by Application (2021-2026) & (US$/Unit) Table 108. Europe Nonsteroidal MRAs Sales Price by Application (2027-2032) & (US$/Unit) Table 109. Europe Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Nonsteroidal MRAs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Nonsteroidal MRAs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. Europe Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 114. Europe Nonsteroidal MRAs Sales by Country (2027-2032) & (K Units) Table 115. Europe Nonsteroidal MRAs Sales Price by Country (2021-2026) & (US$/Unit) Table 116. Europe Nonsteroidal MRAs Sales Price by Country (2027-2032) & (US$/Unit) Table 117. Germany Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 118. France Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 119. U.K. Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 120. Italy Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 121. Russia Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 122. Spain Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 124. Switzerland Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 125. Sweden Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 126. Poland Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 127. China Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 128. China Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 129. China Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 130. China Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 131. China Nonsteroidal MRAs Sales Price by Type (2021-2026) & (US$/Unit) Table 132. China Nonsteroidal MRAs Sales Price by Type (2027-2032) & (US$/Unit) Table 133. China Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 134. China Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 135. China Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 136. China Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 137. China Nonsteroidal MRAs Sales Price by Application (2021-2026) & (US$/Unit) Table 138. China Nonsteroidal MRAs Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 142. Asia Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 143. Asia Nonsteroidal MRAs Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Asia Nonsteroidal MRAs Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Asia Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 148. Asia Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 149. Asia Nonsteroidal MRAs Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Asia Nonsteroidal MRAs Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Nonsteroidal MRAs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Nonsteroidal MRAs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Asia Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 156. Asia Nonsteroidal MRAs Sales by Country (2027-2032) & (K Units) Table 157. Asia Nonsteroidal MRAs Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Asia Nonsteroidal MRAs Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Japan Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 160. South Korea Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 161. India Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 162. Australia Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 163. Taiwan Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Nonsteroidal MRAs Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Nonsteroidal MRAs Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Nonsteroidal MRAs Sales by Type (2021-2026) & (K Units) Table 168. SAMEA Nonsteroidal MRAs Sales by Type (2027-2032) & (K Units) Table 169. SAMEA Nonsteroidal MRAs Sales Price by Type (2021-2026) & (US$/Unit) Table 170. SAMEA Nonsteroidal MRAs Sales Price by Type (2027-2032) & (US$/Unit) Table 171. SAMEA Nonsteroidal MRAs Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Nonsteroidal MRAs Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Nonsteroidal MRAs Sales by Application (2021-2026) & (K Units) Table 174. SAMEA Nonsteroidal MRAs Sales by Application (2027-2032) & (K Units) Table 175. SAMEA Nonsteroidal MRAs Sales Price by Application (2021-2026) & (US$/Unit) Table 176. SAMEA Nonsteroidal MRAs Sales Price by Application (2027-2032) & (US$/Unit) Table 177. SAMEA Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Nonsteroidal MRAs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Nonsteroidal MRAs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. SAMEA Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 182. SAMEA Nonsteroidal MRAs Sales by Country (2027-2032) & (K Units) Table 183. SAMEA Nonsteroidal MRAs Sales Price by Country (2021-2026) & (US$/Unit) Table 184. SAMEA Nonsteroidal MRAs Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Brazil Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 186. Argentina Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 187. Chile Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 188. Colombia Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 189. Peru Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 191. Israel Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 192. UAE Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 193. Turkey Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 194. Iran Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 195. Egypt Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Nonsteroidal MRAs Distributors List Table 199. Nonsteroidal MRAs Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Nonsteroidal MRAs Image Figure 2. Global Nonsteroidal MRAs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nonsteroidal MRAs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Finerenone Image Figure 5. Esaxerenone Image Figure 6. Others Image Figure 7. Global Nonsteroidal MRAs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nonsteroidal MRAs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Heart Failure Image Figure 10. Diabetic Nephropathy Image Figure 11. Hypertension Image Figure 12. Others Image Figure 13. Global Nonsteroidal MRAs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nonsteroidal MRAs Revenue (2021-2032) & (US$ Million) Figure 15. Global Nonsteroidal MRAs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Nonsteroidal MRAs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Nonsteroidal MRAs Revenue Market Share by Region (2021-2032) Figure 18. Global Nonsteroidal MRAs Sales (2021-2032) & (K Units) Figure 19. Global Nonsteroidal MRAs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Nonsteroidal MRAs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Nonsteroidal MRAs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Nonsteroidal MRAs Sales YoY (2021-2032) & (K Units) Figure 23. China Nonsteroidal MRAs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Nonsteroidal MRAs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Nonsteroidal MRAs Sales YoY (2021-2032) & (K Units) Figure 26. Global Nonsteroidal MRAs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Nonsteroidal MRAs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Nonsteroidal MRAs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Nonsteroidal MRAs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nonsteroidal MRAs Revenue Market Share by Type (2021-2032) Figure 32. Global Nonsteroidal MRAs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Nonsteroidal MRAs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Nonsteroidal MRAs Sales Market Share by Type (2021-2032) Figure 35. Global Nonsteroidal MRAs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Nonsteroidal MRAs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nonsteroidal MRAs Revenue Market Share by Application (2021-2032) Figure 38. Global Nonsteroidal MRAs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Nonsteroidal MRAs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Nonsteroidal MRAs Sales Market Share by Application (2021-2032) Figure 41. North America Nonsteroidal MRAs Revenue Share by Type (2021-2032) Figure 42. North America Nonsteroidal MRAs Sales Share by Type (2021-2032) Figure 43. North America Nonsteroidal MRAs Revenue Share by Application (2021-2032) Figure 44. North America Nonsteroidal MRAs Sales Share by Application (2021-2032) Figure 45. North America Nonsteroidal MRAs Revenue Share by Country (2021-2032) Figure 46. North America Nonsteroidal MRAs Sales Share by Country (2021-2032) Figure 47. Europe Nonsteroidal MRAs Revenue Share by Type (2021-2032) Figure 48. Europe Nonsteroidal MRAs Sales Share by Type (2021-2032) Figure 49. Europe Nonsteroidal MRAs Revenue Share by Application (2021-2032) Figure 50. Europe Nonsteroidal MRAs Sales Share by Application (2021-2032) Figure 51. Europe Nonsteroidal MRAs Revenue Share by Country (2021-2032) Figure 52. Europe Nonsteroidal MRAs Sales Share by Country (2021-2032) Figure 53. China Nonsteroidal MRAs Revenue Share by Type (2021-2032) Figure 54. China Nonsteroidal MRAs Sales Share by Type (2021-2032) Figure 55. China Nonsteroidal MRAs Revenue Share by Application (2021-2032) Figure 56. China Nonsteroidal MRAs Sales Share by Application (2021-2032) Figure 57. Asia Nonsteroidal MRAs Revenue Share by Type (2021-2032) Figure 58. Asia Nonsteroidal MRAs Sales Share by Type (2021-2032) Figure 59. Asia Nonsteroidal MRAs Revenue Share by Application (2021-2032) Figure 60. Asia Nonsteroidal MRAs Sales Share by Application (2021-2032) Figure 61. Asia Nonsteroidal MRAs Revenue Share by Country (2021-2032) Figure 62. Asia Nonsteroidal MRAs Sales Share by Country (2021-2032) Figure 63. SAMEA Nonsteroidal MRAs Revenue Share by Type (2021-2032) Figure 64. SAMEA Nonsteroidal MRAs Sales Share by Type (2021-2032) Figure 65. SAMEA Nonsteroidal MRAs Revenue Share by Application (2021-2032) Figure 66. SAMEA Nonsteroidal MRAs Sales Share by Application (2021-2032) Figure 67. SAMEA Nonsteroidal MRAs Revenue Share by Country (2021-2032) Figure 68. SAMEA Nonsteroidal MRAs Sales Share by Country (2021-2032) Figure 69. Nonsteroidal MRAs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Nonsteroidal MRAs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Finerenone
  • Esaxerenone
  • Others
Applications
  • Heart Failure
  • Diabetic Nephropathy
  • Hypertension
  • Others
Companies covered
  • Daiichi Sankyo
  • Bayer
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nonsteroidal MRAs Market by Type
  3. 1.2.1 Global Nonsteroidal MRAs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Finerenone
  5. 1.2.3 Esaxerenone
  6. 1.2.4 Others
  7. 1.3 Nonsteroidal MRAs Market by Application
  8. 1.3.1 Global Nonsteroidal MRAs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Heart Failure
  10. 1.3.3 Diabetic Nephropathy
  11. 1.3.4 Hypertension
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Nonsteroidal MRAs Market Dynamics
  1. 2.1 Nonsteroidal MRAs Industry Trends
  2. 2.2 Nonsteroidal MRAs Industry Drivers
  3. 2.3 Nonsteroidal MRAs Industry Opportunities and Challenges
  4. 2.4 Nonsteroidal MRAs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nonsteroidal MRAs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nonsteroidal MRAs Revenue by Region
  3. 3.2.1 Global Nonsteroidal MRAs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nonsteroidal MRAs Revenue by Region (2021-2026)
  5. 3.2.3 Global Nonsteroidal MRAs Revenue by Region (2027-2032)
  6. 3.2.4 Global Nonsteroidal MRAs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nonsteroidal MRAs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nonsteroidal MRAs Sales by Region
  9. 3.4.1 Global Nonsteroidal MRAs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nonsteroidal MRAs Sales by Region (2021-2026)
  11. 3.4.3 Global Nonsteroidal MRAs Sales by Region (2027-2032)
  12. 3.4.4 Global Nonsteroidal MRAs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nonsteroidal MRAs Revenue by Manufacturers
  2. 4.1.1 Global Nonsteroidal MRAs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nonsteroidal MRAs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nonsteroidal MRAs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nonsteroidal MRAs Sales by Manufacturers
  6. 4.2.1 Global Nonsteroidal MRAs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nonsteroidal MRAs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nonsteroidal MRAs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nonsteroidal MRAs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nonsteroidal MRAs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nonsteroidal MRAs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nonsteroidal MRAs Manufacturers, Product Type & Application
  13. 4.7 Global Nonsteroidal MRAs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nonsteroidal MRAs Market CR5 and HHI
  16. 4.8.2 2025 Nonsteroidal MRAs Tier 1, Tier 2, and Tier 3
5 Nonsteroidal MRAs Market by Type
  1. 5.1 Global Nonsteroidal MRAs Revenue by Type
  2. 5.1.1 Global Nonsteroidal MRAs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nonsteroidal MRAs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nonsteroidal MRAs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nonsteroidal MRAs Sales by Type
  6. 5.2.1 Global Nonsteroidal MRAs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nonsteroidal MRAs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nonsteroidal MRAs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nonsteroidal MRAs Price by Type
6 Nonsteroidal MRAs Market by Application
  1. 6.1 Global Nonsteroidal MRAs Revenue by Application
  2. 6.1.1 Global Nonsteroidal MRAs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nonsteroidal MRAs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nonsteroidal MRAs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nonsteroidal MRAs Sales by Application
  6. 6.2.1 Global Nonsteroidal MRAs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nonsteroidal MRAs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nonsteroidal MRAs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nonsteroidal MRAs Price by Application
7 Company Profiles
  1. 7.1 Daiichi Sankyo
  2. 7.1.1 Daiichi Sankyo Company Information
  3. 7.1.2 Daiichi Sankyo Business Overview
  4. 7.1.3 Daiichi Sankyo Nonsteroidal MRAs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Daiichi Sankyo Nonsteroidal MRAs Product Portfolio
  6. 7.1.5 Daiichi Sankyo Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Nonsteroidal MRAs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Nonsteroidal MRAs Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Sun Pharma
  14. 7.3.1 Sun Pharma Company Information
  15. 7.3.2 Sun Pharma Business Overview
  16. 7.3.3 Sun Pharma Nonsteroidal MRAs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharma Nonsteroidal MRAs Product Portfolio
  18. 7.3.5 Sun Pharma Recent Developments
8 North America
  1. 8.1 North America Nonsteroidal MRAs Market Size by Type
  2. 8.1.1 North America Nonsteroidal MRAs Revenue by Type (2021-2032)
  3. 8.1.2 North America Nonsteroidal MRAs Sales by Type (2021-2032)
  4. 8.1.3 North America Nonsteroidal MRAs Price by Type (2021-2032)
  5. 8.2 North America Nonsteroidal MRAs Market Size by Application
  6. 8.2.1 North America Nonsteroidal MRAs Revenue by Application (2021-2032)
  7. 8.2.2 North America Nonsteroidal MRAs Sales by Application (2021-2032)
  8. 8.2.3 North America Nonsteroidal MRAs Price by Application (2021-2032)
  9. 8.3 North America Nonsteroidal MRAs Market Size by Country
  10. 8.3.1 North America Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nonsteroidal MRAs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nonsteroidal MRAs Market Size by Type
  2. 9.1.1 Europe Nonsteroidal MRAs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nonsteroidal MRAs Sales by Type (2021-2032)
  4. 9.1.3 Europe Nonsteroidal MRAs Price by Type (2021-2032)
  5. 9.2 Europe Nonsteroidal MRAs Market Size by Application
  6. 9.2.1 Europe Nonsteroidal MRAs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nonsteroidal MRAs Sales by Application (2021-2032)
  8. 9.2.3 Europe Nonsteroidal MRAs Price by Application (2021-2032)
  9. 9.3 Europe Nonsteroidal MRAs Market Size by Country
  10. 9.3.1 Europe Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nonsteroidal MRAs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nonsteroidal MRAs Market Size by Type
  2. 10.1.1 China Nonsteroidal MRAs Revenue by Type (2021-2032)
  3. 10.1.2 China Nonsteroidal MRAs Sales by Type (2021-2032)
  4. 10.1.3 China Nonsteroidal MRAs Price by Type (2021-2032)
  5. 10.2 China Nonsteroidal MRAs Market Size by Application
  6. 10.2.1 China Nonsteroidal MRAs Revenue by Application (2021-2032)
  7. 10.2.2 China Nonsteroidal MRAs Sales by Application (2021-2032)
  8. 10.2.3 China Nonsteroidal MRAs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nonsteroidal MRAs Market Size by Type
  2. 11.1.1 Asia Nonsteroidal MRAs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nonsteroidal MRAs Sales by Type (2021-2032)
  4. 11.1.3 Asia Nonsteroidal MRAs Price by Type (2021-2032)
  5. 11.2 Asia Nonsteroidal MRAs Market Size by Application
  6. 11.2.1 Asia Nonsteroidal MRAs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nonsteroidal MRAs Sales by Application (2021-2032)
  8. 11.2.3 Asia Nonsteroidal MRAs Price by Application (2021-2032)
  9. 11.3 Asia Nonsteroidal MRAs Market Size by Country
  10. 11.3.1 Asia Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nonsteroidal MRAs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nonsteroidal MRAs Market Size by Type
  2. 12.1.1 SAMEA Nonsteroidal MRAs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nonsteroidal MRAs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nonsteroidal MRAs Price by Type (2021-2032)
  5. 12.2 SAMEA Nonsteroidal MRAs Market Size by Application
  6. 12.2.1 SAMEA Nonsteroidal MRAs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nonsteroidal MRAs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nonsteroidal MRAs Price by Application (2021-2032)
  9. 12.3 SAMEA Nonsteroidal MRAs Market Size by Country
  10. 12.3.1 SAMEA Nonsteroidal MRAs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nonsteroidal MRAs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nonsteroidal MRAs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nonsteroidal MRAs Value Chain Analysis
  2. 13.1.1 Nonsteroidal MRAs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nonsteroidal MRAs Production Mode & Process
  6. 13.2 Nonsteroidal MRAs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nonsteroidal MRAs Distributors
  9. 13.2.3 Nonsteroidal MRAs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst